{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T12:49:18Z","timestamp":1791895758414,"version":"4.3.4"},"reference-count":76,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100013277","name":"National Clinical Key Specialty Project Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100013277","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Schizophrenia Research"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1016\/j.schres.2026.07.022","type":"journal-article","created":{"date-parts":[[2026,7,25]],"date-time":"2026-07-25T13:33:06Z","timestamp":1784986386000},"page":"26-36","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Association between depressive symptoms, CRP and metabolism-related indicators in Han Chinese patients with chronic schizophrenia"],"prefix":"10.1016","volume":"297","author":[{"given":"Xianlin","family":"Sun","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yachen","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinglei","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pei","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinyue","family":"Xue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xianhu","family":"Yao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenzheng","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lewei","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huanzhong","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.schres.2026.07.022_bb0005","first-page":"953","article-title":"The relationship between insomnia and depressive symptoms in a sample of patients with schizophrenia: do psychotic symptoms play a mediating role?","volume":"32","author":"Abu Khait","year":"2025","journal-title":"J. Psychiatr. Ment. Health Nurs."},{"key":"10.1016\/j.schres.2026.07.022_bb0010","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1192\/S0007125000292581","article-title":"Assessing depression in schizophrenia: the Calgary Depression Scale","volume":"22","author":"Addington","year":"1993","journal-title":"Br. J. Psychiatry Suppl."},{"issue":"7","key":"10.1016\/j.schres.2026.07.022_bb0015","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1007\/s00127-021-02185-8","article-title":"Long term course and outcome of first episode schizophrenia: a 27-to-31-year follow-up","volume":"57","author":"Baltazar","year":"2022","journal-title":"Soc. Psychiatry Psychiatr. Epidemiol."},{"key":"10.1016\/j.schres.2026.07.022_bb0020","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1192\/bjp.154.5.672","article-title":"A rating scale for drug-induced akathisia","volume":"154","author":"Barnes","year":"1989","journal-title":"Br. J. Psychiatry J. Ment. Sci."},{"issue":"4","key":"10.1016\/j.schres.2026.07.022_bb0025","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/S1389-9457(00)00065-4","article-title":"Validation of the Insomnia Severity Index as an outcome measure for insomnia research","volume":"2","author":"Bastien","year":"2001","journal-title":"Sleep Med."},{"issue":"4","key":"10.1016\/j.schres.2026.07.022_bb0030","doi-asserted-by":"crossref","DOI":"10.3390\/ijerph17041350","article-title":"Insomnia in schizophrenia patients: prevalence and quality of life","volume":"17","author":"Batalla-Mart\u00edn","year":"2020","journal-title":"Int. J. Environ. Res. Public Health"},{"issue":"8","key":"10.1016\/j.schres.2026.07.022_bb0035","doi-asserted-by":"crossref","DOI":"10.1038\/tp.2016.133","article-title":"An enzyme in the kynurenine pathway that governs vulnerability to suicidal behavior by regulating excitotoxicity and neuroinflammation","volume":"6","author":"Brundin","year":"2016","journal-title":"Transl. Psychiatry"},{"issue":"3","key":"10.1016\/j.schres.2026.07.022_bb0040","doi-asserted-by":"crossref","DOI":"10.3390\/biom10030384","article-title":"Oxidative-antioxidant imbalance and impaired glucose metabolism in schizophrenia","volume":"10","author":"Bryll","year":"2020","journal-title":"Biomolecules"},{"issue":"7","key":"10.1016\/j.schres.2026.07.022_bb0045","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1016\/j.euroneuro.2019.05.010","article-title":"Increased serum levels of leptin and insulin in both schizophrenia and major depressive disorder: a cross-disorder proteomics analysis","volume":"29","author":"\u00c7akici","year":"2019","journal-title":"Eur. Neuropsychopharmacol."},{"issue":"6349","key":"10.1016\/j.schres.2026.07.022_bb0050","doi-asserted-by":"crossref","DOI":"10.1126\/science.aaf9794","article-title":"Kynurenines: tryptophan\u2019s metabolites in exercise, inflammation, and mental health","volume":"357","author":"Cervenka","year":"2017","journal-title":"Science (New York, N.Y.)"},{"key":"10.1016\/j.schres.2026.07.022_bb0055","article-title":"Depressive symptoms and PANSS symptom dimensions in patients with predominant negative symptom schizophrenia: a network analysis","volume":"13","author":"Demyttenaere","year":"2022","journal-title":"Front. Psychol."},{"key":"10.1016\/j.schres.2026.07.022_bb0060","article-title":"Hyperhomocysteinemia in chronic schizophrenia: prevalence, clinical correlates, and paradoxical associations with symptom severity","author":"Du","year":"2025","journal-title":"Eur. Arch. Psychiatry Clin. Neurosci."},{"key":"10.1016\/j.schres.2026.07.022_bb0065","article-title":"Natural-cause mortality and C-reactive protein levels in patients with schizophrenia spectrum disorders: a prospective total cohort study","volume":"50","author":"Fathian","year":"2025","journal-title":"Brain Behav. Immun. health"},{"key":"10.1016\/j.schres.2026.07.022_bb0070","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1016\/j.jad.2017.09.004","article-title":"High C-reactive protein levels are associated with depressive symptoms in schizophrenia","volume":"225","author":"Faugere","year":"2018","journal-title":"J. Affect. Disord."},{"issue":"9","key":"10.1016\/j.schres.2026.07.022_bb0075","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1038\/s41569-018-0064-2","article-title":"Inflammageing: chronic inflammation in ageing, cardiovascular disease, and frailty","volume":"15","author":"Ferrucci","year":"2018","journal-title":"Nat. Rev. Cardiol."},{"key":"10.1016\/j.schres.2026.07.022_bb0080","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.schres.2021.03.010","article-title":"The role of depression in the prediction of a \u201clate\u201d remission in first-episode psychosis: an analysis of the OPTiMiSE study","volume":"231","author":"Fraguas","year":"2021","journal-title":"Schizophr. Res."},{"issue":"2","key":"10.1016\/j.schres.2026.07.022_bb0085","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1042\/bst0310457","article-title":"Centenarians as a model for healthy aging","volume":"31","author":"Franceschi","year":"2003","journal-title":"Biochem. Soc. Trans."},{"issue":"2\u20133","key":"10.1016\/j.schres.2026.07.022_bb0090","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.schres.2005.03.008","article-title":"Abnormal Involuntary Movement Scale (AIMS) and Extrapyramidal Symptom Rating Scale (ESRS): cross-scale comparison in assessing tardive dyskinesia","volume":"77","author":"Gharabawi","year":"2005","journal-title":"Schizophr. Res."},{"issue":"12","key":"10.1016\/j.schres.2026.07.022_bb0095","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1186\/2047-783X-16-12-549","article-title":"Depressive symptoms in schizophrenic patients","volume":"16","author":"Gozdzik-Zelazny","year":"2011","journal-title":"Eur. J. Med. Res."},{"issue":"4","key":"10.1016\/j.schres.2026.07.022_bb0100","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/S2215-0366(23)00025-1","article-title":"Alteration patterns of peripheral concentrations of cytokines and associated inflammatory proteins in acute and chronic stages of schizophrenia: a systematic review and network meta-analysis","volume":"10","author":"Halstead","year":"2023","journal-title":"Lancet Psychiatry"},{"issue":"15","key":"10.1016\/j.schres.2026.07.022_bb0105","doi-asserted-by":"crossref","first-page":"2463","DOI":"10.1017\/S0033291719002344","article-title":"Depressive psychopathology in first-episode schizophrenia spectrum disorders: a systematic review, meta-analysis and meta-regression","volume":"49","author":"Herniman","year":"2019","journal-title":"Psychol. Med."},{"key":"10.1016\/j.schres.2026.07.022_bb0110","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.schres.2022.12.049","article-title":"Depression trajectories and cytokines in schizophrenia spectrum disorders - a longitudinal observational study","volume":"252","author":"Hoprekstad","year":"2023","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.schres.2026.07.022_bb0115","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajp.2021.102716","article-title":"Abnormal glucose metabolism is associated with clinical symptoms of adolescent-onset patients with first-episode drug-naive schizophrenia","volume":"62","author":"Hu","year":"2021","journal-title":"Asian J. Psychiatr."},{"issue":"3","key":"10.1016\/j.schres.2026.07.022_bb0120","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/S2215-0366(18)30511-X","article-title":"Prevalence of mental disorders in China: a cross-sectional epidemiological study","volume":"6","author":"Huang","year":"2019","journal-title":"Lancet Psychiatry"},{"issue":"3","key":"10.1016\/j.schres.2026.07.022_bb0125","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1080\/13651501.2021.1914664","article-title":"Depression and suicidal ideation in schizophrenia spectrum disorder: a cross-sectional study from a lower middle-income country","volume":"25","author":"Husain","year":"2021","journal-title":"Int. J. Psychiatry Clin. Pract."},{"issue":"8","key":"10.1016\/j.schres.2026.07.022_bb0130","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1001\/jamapsychiatry.2023.1256","article-title":"Cannabis use disorder and subsequent risk of psychotic and nonpsychotic unipolar depression and bipolar disorder","volume":"80","author":"Jefsen","year":"2023","journal-title":"JAMA Psychiatry"},{"issue":"3","key":"10.1016\/j.schres.2026.07.022_bb0135","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1007\/BF01064966","article-title":"Positive-negative symptom assessment in schizophrenia: psychometric issues and scale comparison","volume":"61","author":"Kay","year":"1990","journal-title":"Psychiatry Q."},{"issue":"2","key":"10.1016\/j.schres.2026.07.022_bb0140","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1093\/schbul\/13.2.261","article-title":"The positive and negative syndrome scale (PANSS) for schizophrenia","volume":"13","author":"Kay","year":"1987","journal-title":"Schizophr. Bull."},{"key":"10.1016\/j.schres.2026.07.022_bb0145","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.schres.2024.03.030","article-title":"Longitudinal study of insomnia, suicidal ideation, and psychopathology in schizophrenia","volume":"267","author":"Ketcham","year":"2024","journal-title":"Schizophr. Res."},{"issue":"3","key":"10.1016\/j.schres.2026.07.022_bb0150","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1016\/S2215-0366(14)00122-9","article-title":"Inflammation and immunity in schizophrenia: implications for pathophysiology and treatment","volume":"2","author":"Khandaker","year":"2015","journal-title":"Lancet Psychiatry"},{"issue":"13","key":"10.1016\/j.schres.2026.07.022_bb0155","doi-asserted-by":"crossref","first-page":"2229","DOI":"10.1017\/S0033291717000745","article-title":"Immunopsychiatry: important facts","volume":"47","author":"Khandaker","year":"2017","journal-title":"Psychol. Med."},{"key":"10.1016\/j.schres.2026.07.022_bb0160","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.jpsychires.2018.06.003","article-title":"Trajectories of depressive symptoms in the acute phase of psychosis: implications for treatment","volume":"103","author":"Kjelby","year":"2018","journal-title":"J. Psychiatr. Res."},{"key":"10.1016\/j.schres.2026.07.022_bb0165","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.schres.2022.06.026","article-title":"Could CRP be a differential biomarker of illness stages in schizophrenia? A systematic review and meta-analysis","volume":"246","author":"Lestra","year":"2022","journal-title":"Schizophr. Res."},{"issue":"Suppl. 1","key":"10.1016\/j.schres.2026.07.022_bb0170","doi-asserted-by":"crossref","first-page":"S90","DOI":"10.1093\/schbul\/sbv167","article-title":"Dose equivalents for antipsychotic drugs: the DDD method","volume":"42 Suppl 1","author":"Leucht","year":"2016","journal-title":"Schizophr. Bull."},{"issue":"1","key":"10.1016\/j.schres.2026.07.022_bb0175","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1038\/s41398-021-01196-y","article-title":"The prevalence of depressive and anxiety symptoms and their associations with quality of life among clinically stable older patients with psychiatric disorders during the COVID-19 pandemic","volume":"11","author":"Li","year":"2021","journal-title":"Transl. Psychiatry"},{"key":"10.1016\/j.schres.2026.07.022_bb0180","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.ebiom.2018.07.037","article-title":"Glucose and insulin-related traits, type 2 diabetes and risk of schizophrenia: a Mendelian randomization study","volume":"34","author":"Li","year":"2018","journal-title":"EBioMedicine"},{"key":"10.1016\/j.schres.2026.07.022_bb0185","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.jpsychires.2022.04.029","article-title":"Tardive dyskinesia in Chinese patients with schizophrenia: prevalence, clinical correlates and relationship with cognitive impairment","volume":"151","author":"Liang","year":"2022","journal-title":"J. Psychiatr. Res."},{"key":"10.1016\/j.schres.2026.07.022_bb0190","article-title":"Gender differences of schizophrenia patients with and without depressive symptoms in clinical characteristics","volume":"12","author":"Liu","year":"2021","journal-title":"Front. Psychol."},{"issue":"4","key":"10.1016\/j.schres.2026.07.022_bb0195","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1007\/s00406-023-01684-w","article-title":"One-year efficacy of a lifestyle behavioural intervention on physical and mental health in people with severe mental disorders: results from a randomized controlled trial","volume":"274","author":"Luciano","year":"2024","journal-title":"Eur. Arch. Psychiatry Clin. Neurosci."},{"key":"10.1016\/j.schres.2026.07.022_bb0200","doi-asserted-by":"crossref","DOI":"10.1016\/j.jad.2025.119721","article-title":"Prevalence and predictors of suicidal ideation in patients with chronic schizophrenia: a large-scale study on the mediating roles of depression, insomnia and aggression","volume":"389","author":"Luo","year":"2025","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.schres.2026.07.022_bb0205","doi-asserted-by":"crossref","DOI":"10.1016\/j.pnpbp.2023.110900","article-title":"Association between suicidal behavior and impaired glucose metabolism in first-episode drug-na\u00efve patients with schizophrenia","volume":"129","author":"Ma","year":"2024","journal-title":"Prog. Neuro-Psychopharmacol. Biol. Psychiatry"},{"issue":"4","key":"10.1016\/j.schres.2026.07.022_bb0210","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1080\/15622970500316674","article-title":"Occurrence and treatment of depressive comorbidity\/cosyndromality in schizophrenic psychoses: conceptual and treatment issues","volume":"6","author":"M\u00f6ller","year":"2005","journal-title":"World J. Biol. Psychiatry"},{"key":"10.1016\/j.schres.2026.07.022_bb0215","doi-asserted-by":"crossref","DOI":"10.3389\/fnbeh.2014.00343","article-title":"Homocysteine levels in schizophrenia and affective disorders-focus on cognition","volume":"8","author":"Moustafa A","year":"2014","journal-title":"Front. Behav. Neurosci."},{"issue":"1\u20133","key":"10.1016\/j.schres.2026.07.022_bb0220","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.schres.2015.01.026","article-title":"Effects of depression on the cytokine profile in drug na\u00efve first-episode psychosis","volume":"164","author":"Noto","year":"2015","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.schres.2026.07.022_bb0225","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1016\/j.bbi.2024.06.018","article-title":"Higher substance use is associated with low executive control neural activity and higher inflammation","volume":"120","author":"Nusslock","year":"2024","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.schres.2026.07.022_bb0230","doi-asserted-by":"crossref","DOI":"10.1016\/j.psychres.2022.114887","article-title":"Anxious-depressive symptoms after a first episode of schizophrenia: response to treatment and psychopathological considerations from the 2-year \u201cParma Early Psychosis\u201d program","volume":"317","author":"Pelizza","year":"2022","journal-title":"Psychiatry Res."},{"key":"10.1016\/j.schres.2026.07.022_bb0235","doi-asserted-by":"crossref","DOI":"10.1016\/j.pnpbp.2023.110899","article-title":"Inter-relationships of insomnia and psychiatric symptoms with suicidal ideation among patients with chronic schizophrenia: a network perspective","volume":"129","author":"Peng","year":"2024","journal-title":"Prog. Neuro-Psychopharmacol. Biol. Psychiatry"},{"issue":"3","key":"10.1016\/j.schres.2026.07.022_bb0240","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1003455","article-title":"The potential shared role of inflammation in insulin resistance and schizophrenia: a bidirectional two-sample Mendelian randomization study","volume":"18","author":"Perry","year":"2021","journal-title":"PLoS Med."},{"issue":"4","key":"10.1016\/j.schres.2026.07.022_bb0245","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1111\/j.1600-0447.1991.tb03161.x","article-title":"Reliability and validity of the Chinese versions of the scales for assessment of positive and negative symptoms","volume":"84","author":"Phillips","year":"1991","journal-title":"Acta Psychiatr. Scand."},{"issue":"3","key":"10.1016\/j.schres.2026.07.022_bb0250","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1001\/jamapsychiatry.2016.3803","article-title":"Impaired glucose homeostasis in first-episode schizophrenia: a systematic review and meta-analysis","volume":"74","author":"Pillinger","year":"2017","journal-title":"JAMA Psychiatry"},{"issue":"1","key":"10.1016\/j.schres.2026.07.022_bb0255","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/S2215-0366(19)30416-X","article-title":"Comparative effects of 18 antipsychotics on metabolic function in patients with schizophrenia, predictors of metabolic dysregulation, and association with psychopathology: a systematic review and network meta-analysis","volume":"7","author":"Pillinger","year":"2020","journal-title":"Lancet Psychiatry"},{"issue":"1","key":"10.1016\/j.schres.2026.07.022_bb0260","first-page":"30","article-title":"Adult stress exposure blunts dopamine system hyperresponsivity in a neurodevelopmental rodent model of schizophrenia","volume":"8","author":"Rinc\u00f3n-Cort\u00e9s","year":"2022","journal-title":"Schizophrenia (Heidelberg, Germany)"},{"issue":"2\u20133","key":"10.1016\/j.schres.2026.07.022_bb0265","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/S0920-9964(02)00490-5","article-title":"Cross-cultural adaptation and validation of the Spanish version of the Calgary Depression Scale for Schizophrenia","volume":"68","author":"Sarr\u00f3","year":"2004","journal-title":"Schizophr. Res."},{"issue":"1","key":"10.1016\/j.schres.2026.07.022_bb0270","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1192\/bjp.168.1.68","article-title":"Relationships among negative, positive, and depressive symptoms in schizophrenia and psychotic depression","volume":"168","author":"Sax","year":"1996","journal-title":"Br. J. Psychiatry"},{"issue":"2","key":"10.1016\/j.schres.2026.07.022_bb0275","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.psychres.2004.07.007","article-title":"Subjective quality of life in first episode schizophrenia spectrum disorders with comorbid depression","volume":"129","author":"Sim","year":"2004","journal-title":"Psychiatry Res."},{"key":"10.1016\/j.schres.2026.07.022_bb0280","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1111\/j.1600-0447.1970.tb02066.x","article-title":"A rating scale for extrapyramidal side effects","volume":"212","author":"Simpson","year":"1970","journal-title":"Acta Psychiatr. Scand. Suppl."},{"key":"10.1016\/j.schres.2026.07.022_bb0285","article-title":"Depression in schizophrenia: prevalence and its impact on quality of life, disability, and functioning","volume":"54","author":"Subodh","year":"2020","journal-title":"Asian J. Psychiatr."},{"key":"10.1016\/j.schres.2026.07.022_bb0290","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.schres.2020.03.038","article-title":"Relationship of poor insight to neurocognition, social cognition, and psychiatric symptoms in schizophrenia: a meta-analysis","volume":"220","author":"Subotnik","year":"2020","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.schres.2026.07.022_bb0295","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajp.2021.102578","article-title":"Relationship between subjective quality of life and perceptions of recovery orientation of treatment service in patients with schizophrenia and major depressive disorder","volume":"57","author":"Sum","year":"2021","journal-title":"Asian J. Psychiatr."},{"key":"10.1016\/j.schres.2026.07.022_bb0300","doi-asserted-by":"crossref","DOI":"10.1016\/j.pnpbp.2019.109679","article-title":"Evaluation of hyperhomocysteinemia prevalence and its influence on the selected cognitive functions in patients with schizophrenia","volume":"95","author":"Trze\u015bniowska-Druka\u0142a","year":"2019","journal-title":"Prog. Neuro-Psychopharmacol. Biol. Psychiatry"},{"issue":"2","key":"10.1016\/j.schres.2026.07.022_bb0305","first-page":"240","article-title":"Depression and schizophrenia: cause, consequence, or trans-diagnostic issue?","volume":"43","author":"Upthegrove","year":"2017","journal-title":"Schizophr. Bull."},{"issue":"3","key":"10.1016\/j.schres.2026.07.022_bb0310","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1097\/YCO.0000000000000791","article-title":"Unhealthy diet in schizophrenia spectrum disorders","volume":"35","author":"van Zonneveld","year":"2022","journal-title":"Curr. Opin. Psychiatry"},{"key":"10.1016\/j.schres.2026.07.022_bb0315","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.jad.2021.08.015","article-title":"Suicide attempts are associated with activated immune-inflammatory, nitro-oxidative, and neurotoxic pathways: a systematic review and meta-analysis","volume":"295","author":"Vasupanrajit","year":"2021","journal-title":"J. Affect. Disord."},{"issue":"1","key":"10.1016\/j.schres.2026.07.022_bb0320","doi-asserted-by":"crossref","DOI":"10.1136\/gpsych-2018-100026","article-title":"Study on risk factors of extrapyramidal symptoms induced by antipsychotics and its correlation with symptoms of schizophrenia","volume":"32","author":"Weng","year":"2019","journal-title":"Gen. Psychiatry"},{"issue":"5","key":"10.1016\/j.schres.2026.07.022_bb0325","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1001\/jamapsychiatry.2022.0407","article-title":"Inflammation and brain structure in schizophrenia and other neuropsychiatric disorders: a Mendelian randomization study","volume":"79","author":"Williams","year":"2022","journal-title":"JAMA Psychiatry"},{"issue":"1","key":"10.1016\/j.schres.2026.07.022_bb0330","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1038\/s41398-024-02800-7","article-title":"Prefrontal cortical dopamine deficit may cause impaired glucose metabolism in schizophrenia","volume":"14","author":"Wu","year":"2024","journal-title":"Transl. Psychiatry"},{"issue":"10","key":"10.1016\/j.schres.2026.07.022_bb0335","doi-asserted-by":"crossref","first-page":"2137","DOI":"10.1002\/jclp.23141","article-title":"Depressive symptoms, anxiety symptoms, and their co-occurrence among people living with schizophrenia in China: prevalence and correlates","volume":"77","author":"Xi","year":"2021","journal-title":"J. Clin. Psychol."},{"issue":"1","key":"10.1016\/j.schres.2026.07.022_bb0340","first-page":"105","article-title":"Prevalence and correlates of insomnia and its impact on quality of life in Chinese schizophrenia patients","volume":"32","author":"Xiang","year":"2009","journal-title":"Sleep"},{"issue":"6","key":"10.1016\/j.schres.2026.07.022_bb0345","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1080\/00048670902873672","article-title":"Reliability and validity of the Chinese version of the Calgary Depression Scale for Schizophrenia","volume":"43","author":"Xiao","year":"2009","journal-title":"Aust. N. Z. J. Psychiatry"},{"key":"10.1016\/j.schres.2026.07.022_bb0350","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1016\/j.psychres.2018.04.016","article-title":"Depressive symptoms in Chinese male inpatients with schizophrenia: prevalence and clinical correlates","volume":"264","author":"Xu","year":"2018","journal-title":"Psychiatry Res."},{"key":"10.1016\/j.schres.2026.07.022_bb0355","doi-asserted-by":"crossref","DOI":"10.1016\/j.neubiorev.2025.106218","article-title":"Insulin resistance: the role in comorbid type 2 diabetes mellitus and depression","volume":"175","author":"Yao","year":"2025","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.schres.2026.07.022_bb0360","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.jad.2020.03.121","article-title":"Homocysteine, but not MTHFR gene polymorphism, influences depressive symptoms in patients with schizophrenia","volume":"272","author":"Zhang","year":"2020","journal-title":"J. Affect. Disord."},{"issue":"1","key":"10.1016\/j.schres.2026.07.022_bb0365","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1186\/s12888-025-06905-1","article-title":"White matter hyperintensities, inflammation and cognitive impairments in drug-na\u00efve first episode schizophrenia patients: a cross-sectional study","volume":"25","author":"Zhang","year":"2025","journal-title":"BMC Psychiatry"},{"key":"10.1016\/j.schres.2026.07.022_bb0370","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1016\/j.jad.2024.07.130","article-title":"Depressive and anxiety symptoms among schizophrenia patients","volume":"362","author":"Zhao","year":"2024","journal-title":"J. Affect. Disord."},{"issue":"1","key":"10.1016\/j.schres.2026.07.022_bb0375","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1186\/s12888-024-05929-3","article-title":"Exploring the interplay of psychiatric symptoms, antipsychotic medications, side effects, employment status, and quality of life in chronic schizophrenia","volume":"24","author":"Zhou","year":"2024","journal-title":"BMC Psychiatry"},{"key":"10.1016\/j.schres.2026.07.022_bb0380","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.schres.2021.12.045","article-title":"Sex difference in association between insomnia and cognitive impairment in patients with chronic schizophrenia","volume":"240","author":"Zhu","year":"2022","journal-title":"Schizophr. Res."}],"container-title":["Schizophrenia Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0920996426002318?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0920996426002318?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T12:08:40Z","timestamp":1791893320000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0920996426002318"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,11]]},"references-count":76,"alternative-id":["S0920996426002318"],"URL":"https:\/\/doi.org\/10.1016\/j.schres.2026.07.022","relation":{},"ISSN":["0920-9964"],"issn-type":[{"value":"0920-9964","type":"print"}],"subject":[],"published":{"date-parts":[[2026,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Association between depressive symptoms, CRP and metabolism-related indicators in Han Chinese patients with chronic schizophrenia","name":"articletitle","label":"Article Title"},{"value":"Schizophrenia Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.schres.2026.07.022","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}